The 20 Best Vogt-Koyanagi-Harada Disease Doctors Near Me in New York, US

Naomi Goldberg is an Ophthalmologist practicing medicine in New York, New York. Dr. Goldberg is rated as an Advanced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Uveitis, Birdshot Chorioretinopathy, Scleritis, and Neuroretinitis. Dr. Goldberg is board certified in American Board Of Ophthalmology.

Yu Hyon Kim, MD, is an attending physician, Retina and Assistant Professor, Ophthalmology & Visual Sciences at Montefiore Einstein. His clinical focus is in all aspects of vitreoretinal diseases evaluation, treatment and surgery, with a special interest in retinovascular disease, diabetes, macular degeneration, sickle cell and vascular occlusions. Dr. Kim is rated as an Experienced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Diabetic Retinopathy, Retinal Artery Occlusion, Retinal Detachment, and Retinal Vein Occlusion.

Matthew S. Wieder, MD, is an attending physician, Retina Specialist, Assistant Professor, Ophthalmology & Visual Sciences and Associate Director, Ophthalmology Residency Training Program at Montefiore Einstein. With subspecialty training in vitreoretinal surgery, Dr. Wieder specializes in the medical and surgical management of all disorders of the retina and vitreous. Dr. Wieder is rated as an Experienced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. His clinical expertise encompasses Diabetic Retinopathy, Retinal Artery Occlusion, Vogt-Koyanagi-Harada Disease, and Retinal Detachment.

Jonathan Jonisch is an Ophthalmologist practicing medicine in Great Neck, New York. Dr. Jonisch is rated as an Experienced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, and Retinal Vein Occlusion. Dr. Jonisch is board certified in American Board Of Ophthalmology.

Saadia Rashid is an Ophthalmologist practicing medicine in Bronx, New York. Dr. Rashid is rated as an Experienced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Diabetic Retinopathy, Retinal Detachment, Age-Related Macular Degeneration (ARMD), and Late-Onset Retinal Degeneration.

Norman Saffra is an Ophthalmologist practicing medicine in Hewlett, New York. Dr. Saffra is rated as an Experienced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Detachment, Cataract, and Cataract Removal.

Irmak Karaca is an Ophthalmologist practicing medicine in New York, New York. She has been practicing medicine for over 13 years. Dr. Karaca is rated as an Experienced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Uveitis, Episcleritis, Scleritis, Vitrectomy, and Cataract Removal.

David Immanuel is an Ophthalmologist practicing medicine in Hauppauge, New York. Dr. Immanuel is rated as an Experienced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Pterygium, Eyelid Bump, Meibomianitis, and Subconjunctival Hemorrhage.

Jay Fleischman is an Ophthalmologist practicing medicine in Bronx, New York. Dr. Fleischman is rated as an Experienced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Age-Related Macular Degeneration (ARMD), Kallikrein Hypertension, Late-Onset Retinal Degeneration, and Geographic Atrophy.

Gaurav Chandra is an Ophthalmologist practicing medicine in Yonkers, New York. Dr. Chandra is rated as an Advanced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. He is also highly rated in 49 other conditions, according to our data. His clinical expertise encompasses Endophthalmitis, Neuroretinitis, Uveitis, Late-Onset Retinal Degeneration, and Vitrectomy.

Carl Wilkins is an Ophthalmologist practicing medicine in New York, New York. Dr. Wilkins is rated as an Advanced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Uveitis, Endophthalmitis, Eales Disease, Vitrectomy, and Cataract Removal.

Edward Marcus is an Ophthalmologist practicing medicine in Brentwood, New York. Dr. Marcus is rated as an Advanced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Diabetic Retinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Kallikrein Hypertension, and Vitrectomy.

Deep Parikh is an Ophthalmologist practicing medicine in New York, New York. Dr. Parikh is rated as an Advanced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Neuroretinitis, Uveitis, Endophthalmitis, and Scleritis.

Joseph Tseng is an Ophthalmologist practicing medicine in New York, New York. Dr. Tseng is rated as an Advanced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Diabetic Retinopathy, Retinal Detachment, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Vitrectomy.

Brian Marr, MD heads the Ophthalmic Oncology Service at the Harkness Eye Institute. He has comprehensive experience in the diagnosis, treatment, and management of ocular tumors including intraocular tumor resection, laser, radiation, and chemotherapy procedures. He has helped devise thousands of complex treatments for tumors of the eye, eyelid, orbit, and conjunctiva for his adult, children, and infant patients. Currently, Dr. Marr is a collaborator on a Columbia University clinical trial for a first-of-its-kind, new class of drug treatment for uveal melanoma.Dr. Marr is a board-certified ophthalmologist whose work has centered around ophthalmic oncology since 2000. One of the very few ocular oncologists trained in all aspects of eye cancer, Dr. Marr's clinical experience in treating these diseases is among the most extensive in the United States. His interest and experience in ophthalmic oncology began during an eight-year tenure in the Ocular Oncology Service at the Wills Eye Hospital in Philadelphia. There, he gained extensive experience treating intraocular tumors, and tumors of the eyelid, orbit, and conjunctiva in children and adults. It was there that Dr. Marr developed and improved many surgical procedures used to cure cancers of the eye, successfully treated thousands of patients, and helped their families though their battle with eye cancer. Next, Dr. Marr moved on to Memorial Sloan Kettering Cancer Center, where he remain for nine years, starting in 2008.Dr. Marr has some of the greatest experience with intra-arterial chemotherapy for treating retinoblastoma in the country, if not the world, as well as all other forms of retinoblastoma treatment. He has been a key member of many multidisciplinary surgical teams, treating advanced skull base tumors and complex facial skin lesions. He has developed a strong belief and treatment philosophy that the best research be used to help his patients, rather than his best patients be used to help his research. The field of ophthalmic oncology encompasses many rare conditions and his experience helps his patients get the best care and results as quickly as possible. Dr. Marr lectures and consults across the US and abroad, and has authored numerous research articles in the field of ocular oncology. He is the principal investigator in a first-in-class drug study for treating primary uveal melanoma, in an international, multi-center trial. He also volunteers his medical expertise in underserviced parts of the world, such as Nigeria and Indonesia, and has helped train physicians in more than 20 countries. Dr. Marr’s efforts as a contributor to ongoing education in ocular oncology have been recognized by the American Academy of Ophthalmology, where he now serves as chief editor of the Academy’s Oncology and Pathology’s One network. Dr. Marr is rated as an Experienced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Retinoblastoma, Melanoma of the Eye, Metastatic Uveal Melanoma, Uveal Melanoma, and Vitrectomy. Dr. Marr is board certified in Ophthalmology. Dr. Marr is currently accepting new patients.

Scott E. Brodie, MD, Ph.D., is a Professor of Clinical Ophthalmology and Attending Ophthalmologist in the Department of Ophthalmology. He is an internationally known clinician-scientist, and a leader in the use of electrophysiologic techniques for diagnosing of visual impairments in children and adults.Dr. Brodie is a graduate of the combined MD-PhD program at Weill-Cornell Medical College and The Rockefeller University in New York. He completed his PhD in retinal physiology in the laboratory of Nobel Laureate H. K. Hartline, under the supervision of Dr. Floyd Ratliff and Prof. Bruce Knight. He completed a medical internship and residency training in ophthalmology at The New York Hospital, and subsequently received fellowship training in medical retinal disorders and clinical electrophysiology of vision at New York University and Bellevue Hospital under the supervision of Dr. Ronald Carr, with support as a John Kluge Fellow of the Retinitis Pigmentosa Foundation.He is a fellow of the American Academy of Ophthalmology, and a fellow of the Association for Research in Vision and Ophthalmology. He is a member of the International Society for Clinical Electrophysiology of Vision, the International Society for Genetic Eye Disease, and the Ophthalmic Genetics Study Club. Dr. Brodie has been honored with the Senior Achievement Award of the American Academy of Ophthalmology, as well as the Academy's Secretariat Award for Education.Dr. Brodie’s research centers on improving methodologies for electrophysiologic testing, and descriptions of novel findings in patients with inherited and metabolic retinal disorders. He has been a key member of the teams which have introduced important new therapies, including enzyme-replacement therapy for Fabry disease, and intra-arterial chemotherapy for retinoblastoma, which has increased the rate of salvage of diseased eyes in the most severely affected patients from 20% to over 90%.Dr. Brodie has published extensively on electrophysiology and retinal disorders. He has a particular interest in clinical optics, and has served as Chair of the Editorial committee for the American Academy of Ophthalmology’s Basic and Clinical Science Course on Clinical Optics for the past ten years. In his spare time, he enjoys reading mathematics, and playing the oboe in local orchestras and chamber groups. Dr. Brodie is rated as an Experienced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Retinoblastoma, Retinitis Pigmentosa, Cone-Rod Dystrophy, Retinopathy Pigmentary Mental Retardation, and Vitrectomy. Dr. Brodie is currently accepting new patients.

Ying Qian is an Ophthalmologist practicing medicine in Rochester, New York. Dr. Qian is rated as an Experienced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Uveitis, Vogt-Koyanagi-Harada Disease, Neurotrophic Keratitis, and Endophthalmitis.

Robert Swan is an Ophthalmologist practicing medicine in Syracuse, New York. Dr. Swan is rated as an Experienced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Scleritis, Cicatricial Pemphigoid, Uveitis, Trabeculectomy, and Vitrectomy.

Nitish Mehta is an Ophthalmologist practicing medicine in New York, New York. Dr. Mehta is rated as an Experienced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Retinal Vein Occlusion, Diabetic Retinopathy, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Vitrectomy.

Pawan Bhatnagar is an Ophthalmologist practicing medicine in Slingerlands, New York. He has been practicing medicine for over 24 years. Dr. Bhatnagar is rated as an Experienced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Retinal Detachment, Uveitis, Eales Disease, and Late-Onset Retinal Degeneration. Dr. Bhatnagar is board certified in American Board Of Ophthalmology. Dr. Bhatnagar is currently accepting new patients.